Effector Therapeutics Inc's ROI from its first quarter of 2024 to the first quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Effector Therapeutics Inc's ROI in the first quarter of 2024?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Effector Therapeutics Inc 's return on investment (ROI) in its first quarter of 2024

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter
Y / Y Investment Change TTM	-	-	-	-89.2 %	-72.78 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	2	-5	-3	3	-5
Return On Investment (TTM)	3474.39 %	-	-	-1055.91 %	-
EFTR's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-54.32 %	-62.58 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-35	-36	-36	-37	-36

EFTR Company Profile >> Back to EFTR Roi Comparisons >> See Annual EFTR Return On Investment

Return On Investment EFTR's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Effector Therapeutics Inc's I. Quarter Investments	$ 2 Millions	EFTR's Balance sheet
Effector Therapeutics Inc's I. Quarter Income	$ -9 Millions	Quarterly EFTR's Income Statement
EFTR's Income by Division		See EFTR's Income by Division

EFTR Annual Return On Investment	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	-5	4	50	0	0
Y / Y Investment Growth	-	-92.01 %	-	-	-
Net Income in Millions	-36	-23	16	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-566.34 %	31.55 %	-	-

Annual Roi Comment

Despite deterioration in net income, company improved ROI to in the fiscal year 2023, company improved ROI to 31.55 % compare to previous year.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EFTR's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EFTR's Competitors
Subscribers only: Roi for Effector Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for EFTR's Customers

Other Ratios
EFTR's Roa	EFTR's Inventory Turnover Ratio	EFTR's Growth Rates	EFTR's Dividend Statistics
	EFTR's Profitability Ratios	EFTR's Asset Turnover Ratio	EFTR's Dividend Growth
EFTR's Roe	EFTR's Valuation Ratios	EFTR's Financial Strength Ratios	EFTR's Dividend Payout Ratio

Companies with similar Return On Investment at Mar 31 2024, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:39:44+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.